Smartwatches were able to detect atrial fibrillation when paired with a deep neural network, according to a study published today in JAMA. While the technology had the ability to passively detected atrial fibrillation, there was some loss of sensitivity and specificity against the gold-standard ECG.
from MobiHealthNews http://ift.tt/2GQJdKL
March 21, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Benchling gets $14.5M to build collaboration tools for biotechs, pharmasBenchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.5 million in series B funding. Benchmark led the round, with additional partici… Read More
Valencell's partnership with earphone manufacturer leads to $10.5M raiseBiometric sensor technology company Valencell announced this week that it has raised $10.5 million in Series E, bringing the company’s total funding to $35 million. The new backing primarily comes as the result of a strategic… Read More
FDA approves wearable device for opioid withdrawal symptom treatment deviceDyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withd… Read More
Studies lend credence to Click Therapeutics' digital therapeutic for depressionThe past month has seen a succession of publications offering support for Click Therapeutics’ digital offering for patients with major depressive disorder (MDD). from MobiHealthNews https://ift.tt/2JVMBYW … Read More
Digital brain biomarker startup raises $15M in Series B fundingMindstrong Health, a company that uses phone activity to measure mental health and behavior, has just closed a $15 million Series B funding round. This newest backing brings the startups total financing to $29 million, … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment